Literature DB >> 18759336

A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome.

Cecilia Marelli1, Laura Canafoglia, Federica Zibordi, Claudia Ciano, Elisa Visani, Giovanna Zorzi, Barbara Garavaglia, Chiara Barzaghi, Alberto Albanese, Paola Soliveri, Massimo Leone, Ferruccio Panzica, Vidmer Scaioli, Alessandro Pincherle, Nardo Nardocci, Silvana Franceschetti.   

Abstract

Mutations in the epsilon-sarcoglycan (SGCE) gene have been associated with DYT11 myoclonus-dystonia syndrome (MDS). The aim of this study was to characterize myoclonus in 9 patients with DYT11-MDS presenting with predominant myoclonus and mild dystonia by means of neurophysiological techniques. Variously severe multifocal myoclonus occurred in all of the patients, and included short (mean 89.1 +/- 13.3 milliseconds) electromyographic bursts without any electroencephalographic correlate, sometimes presenting a pseudo-rhythmic course. Massive jerks could be evoked by sudden stimuli in 5 patients, showing a "startle-like" muscle spreading and latencies consistent with a brainstem origin. Somatosensory evoked potentials and long-loop reflexes were normal, as was silent period and long-term intracortical inhibition evaluated by means of transcranial magnetic stimulation; however, short-term intracortical inhibition revealed subtle impairment, and event-related synchronization (ERS) in the beta band was delayed. Blink reflex recovery was strongly enhanced. Myoclonus in DYT11-MDS seems to be generated at subcortical level, and possibly involves basal ganglia and brainstem circuitries. Cortical impairment may depend from subcortical dysfunction, but it can also have a role in influencing the myoclonic presentation. The wide distribution of the defective SCGE in DYT11-MDS may justify the involvement of different brain areas. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759336     DOI: 10.1002/mds.22256

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

Review 1.  Phenomenology and classification of dystonia: a consensus update.

Authors:  Alberto Albanese; Kailash Bhatia; Susan B Bressman; Mahlon R Delong; Stanley Fahn; Victor S C Fung; Mark Hallett; Joseph Jankovic; Hyder A Jinnah; Christine Klein; Anthony E Lang; Jonathan W Mink; Jan K Teller
Journal:  Mov Disord       Date:  2013-05-06       Impact factor: 10.338

2.  SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?

Authors:  Katja Ritz; Barbera Dc van Schaik; Marja E Jakobs; Antoine H van Kampen; Eleonora Aronica; Marina A Tijssen; Frank Baas
Journal:  Eur J Hum Genet       Date:  2010-12-15       Impact factor: 4.246

Review 3.  What's new in dystonia?

Authors:  Vicki Shanker; Susan B Bressman
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

4.  Clinical and neurophysiological improvement of SGCE myoclonus-dystonia with GPi deep brain stimulation.

Authors:  Monica M Kurtis; Marta San Luciano; Qiping Yu; Robert R Goodman; Blair Ford; Deborah Raymond; Seth L Pullman; Rachel Saunders-Pullman
Journal:  Clin Neurol Neurosurg       Date:  2009-11-05       Impact factor: 1.876

5.  Myoclonus-dystonia syndrome: case report.

Authors:  Emel Oguz Akarsu; Reyhan Surmeli; Destina Yalcin
Journal:  North Clin Istanb       Date:  2015-01-24

Review 6.  Myoclonic Disorders.

Authors:  Olaf Eberhardt; Helge Topka
Journal:  Brain Sci       Date:  2017-08-14

7.  Familial cortical myoclonus with a mutation in NOL3.

Authors:  Jonathan F Russell; Jamie L Steckley; Giovanni Coppola; Angelika F G Hahn; MacKenzie A Howard; Zachary Kornberg; Alden Huang; Seyed M Mirsattari; Barry Merriman; Eric Klein; Murim Choi; Hsien-Yang Lee; Andrew Kirk; Carol Nelson-Williams; Gillian Gibson; Scott C Baraban; Richard P Lifton; Daniel H Geschwind; Ying-Hui Fu; Louis J Ptáček
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

8.  The phenotypic spectrum of DYT24 due to ANO3 mutations.

Authors:  Maria Stamelou; Gavin Charlesworth; Carla Cordivari; Susanne A Schneider; Georg Kägi; Una-Marie Sheerin; Ignacio Rubio-Agusti; Amit Batla; Henry Houlden; Nicholas W Wood; Kailash P Bhatia
Journal:  Mov Disord       Date:  2014-01-17       Impact factor: 10.338

9.  Phenotypic insights into ADCY5-associated disease.

Authors:  Florence C F Chang; Ana Westenberger; Russell C Dale; Martin Smith; Hardev S Pall; Belen Perez-Dueñas; Padraic Grattan-Smith; Robert A Ouvrier; Neil Mahant; Bernadette C Hanna; Matthew Hunter; John A Lawson; Christoph Max; Rani Sachdev; Esther Meyer; Dennis Crimmins; Donald Pryor; John G L Morris; Alex Münchau; Detelina Grozeva; Keren J Carss; Lucy Raymond; Manju A Kurian; Christine Klein; Victor S C Fung
Journal:  Mov Disord       Date:  2016-04-08       Impact factor: 10.338

10.  ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.

Authors:  Miryam Carecchio; Niccolò E Mencacci; Alessandro Iodice; Roser Pons; Celeste Panteghini; Giovanna Zorzi; Federica Zibordi; Anastasios Bonakis; Argyris Dinopoulos; Joseph Jankovic; Leonidas Stefanis; Kailash P Bhatia; Valentina Monti; Lea R'Bibo; Liana Veneziano; Barbara Garavaglia; Carlo Fusco; Nicholas Wood; Maria Stamelou; Nardo Nardocci
Journal:  Parkinsonism Relat Disord       Date:  2017-05-10       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.